Financial insights of ATRA

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total revenue	-	30,193*	-	-
Commercialization revenue	516	-	3,453	17,575
Cost of commercialization revenue	124	20,209*	115	554
Research and development expenses	164	-36,945*	2,925	7,310
General and administrative expenses	3,597	10,502*	3,987	6,514
Total costs and operating expenses	3,885	-6,235*	7,027	14,378
Income (loss) from operations	-3,369	36,428*	-3,574	3,197
Interest income	54	163*	204	143
Interest expense	830	971*	909	972
Other income (expense), net	0	-73*	4	22
Total other income (expense), net	-776	-881*	-701	-807
Income (loss) before provision for (benefit from) income taxes	-4,145	35,547*	-4,275	2,390
Provision for (benefit from) income taxes	0	-15*	28	3
Net income (loss)	-4,145	35,562*	-4,303	2,387
Unrealized gain (loss) on available-for-sale securities	-1	-10*	2	0
Comprehensive income (loss)	-4,146	35,552	-4,301	2,387

Basic EPS	-0.29	2.995	-0.32	0.2
Diluted EPS	-0.29	2.895	-0.32	0.19
Basic Average Shares	14,081,000	11,871,000	13,564,000	12,197,000
Diluted Average Shares	14,081,000	12,280,000	13,564,000	12,310,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.